Yani Pan
Nanjing, 210000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NNMT and the methylation sink: integrating metabolism, epigenetics and immunity in cancer.
Journal: BMC medicine
Published: February 09, 2026
Targeting the USP5-HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 23, 2025
Pharmacological induction of acetyl-CoA carboxylase 1 autophagic degradation attenuates lipid accumulation and cholangiocarcinoma progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 16, 2025
RBM8A confers oxaliplatin resistance in gastric cancer by maintaining EGFR mRNA stability.
Journal: Oncogene
Published: April 30, 2025
Mitochondria-targeting polymer cLipG/CuET activates the cGAS/STING pathway to enhance cholangiocarcinoma immunotherapy.
Journal: Journal of nanobiotechnology
Published: March 05, 2025
TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progression.
Journal: JHEP reports : innovation in hepatology
Published: January 21, 2025
Targeting GPX2 to disrupt lipid homeostasis and enhance cisplatin sensitivity in diffuse gastric cancer.
Journal: Cell death discovery
Published: September 05, 2024
Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2-Mediated Unfolded Protein Reaction Activation.
Journal: Advanced healthcare materials
Published: March 22, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026